Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma [Phase 1]
Phase 1 clinical study of TQB2029 for injection in subjects with multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM) [Phase 2]
Phase 2 clinical trial update on pomalidomide for relapsed and refractory multiple myeloma (RRMM).
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma [Phase 3]
Phase 3 clinical trial update on managing pain and chemotherapy-related symptoms in people with multiple myeloma or lymphoma, with results p…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy [Phase 2]
This clinical trial update reports Phase 2 results for Descartes-11 used as consolidation therapy in high-risk multiple myeloma patients wit…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies [Phase 2]
This Phase 2 trial studied the combination of lenalidomide and ipilimumab after stem cell transplantation in patients with hematologic or ly…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma [Phase 1]
A Phase I study evaluating CBG002 CAR-T cell therapy for relapsed or refractory multiple myeloma; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China [Phase 1]
Phase 1 clinical trial update evaluating Maplirpacept in advanced non-Hodgkin lymphoma or multiple myeloma in China has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Mobile Health Device Study for Myeloma Patients
A completed clinical trial evaluating a mobile health device for patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial [Phase 2]
Phase 2 randomized trial evaluating the efficacy of anakinra for managing fever during neutropenia and mucositis in autologous stem cell tra…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT [Phase 2]
Phase 2 trial evaluating the safety and efficacy of anakinra for managing fever during neutropenia and mucositis in autologous stem cell tra…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd) [Phase 1, Phase 2]
A Phase 1/2 clinical trial update on weekly combination therapy with carfilzomib, cyclophosphamide, and dexamethasone (wCCyd) in newly diagn…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL [Phase 1]
Phase 1 trial evaluating haploidentical stem cell transplantation with prophylactic natural killer donor lymphocyte infusion in lymphoma, mu…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Descartes-25 in Relapsed/Refractory Multiple Myeloma [Phase 1]
Descartes-25, a candidate from Cartesian Therapeutics, in relapsed/refractory multiple myeloma has a terminated Phase 1 study; no efficacy r…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression [Phase 2]
Phase 2 trial evaluating low-dose lenalidomide with dexamethasone in relapsed/refractory multiple myeloma patients at high risk for myelosup…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating romidepsin with lenalidomide in adults with relapsed or refractory lymphomas and multiple myeloma has completed w…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients [Phase 3]
Phase 3 trial comparing three lenalidomide-based regimens in elderly multiple myeloma patients; lenalidomide+dexamethasone vs melphalan-pred…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: MInimal Residual Disease Adapted Strategy [Phase 3]
This is a Phase 3 clinical trial update for a Minimal Residual Disease adapted strategy in Multiple Myeloma, sponsored by Intergroupe Franco…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects [Phase 3]
Phase 3 trial in newly diagnosed multiple myeloma comparing cyclophosphamide, lenalidomide, and dexamethasone induction with autologous stem…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies [Phase 1]
Pfizer's Maplirpacept (PF-07901801) Phase 1 trial in hematologic malignancies (lymphoma and multiple myeloma) has completed enrollment/statu…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: MargheRITA (Remote Intelligence for Therapeutic Adherence) [NA]
A completed clinical trial named MargheRITA (Remote Intelligence for Therapeutic Adherence) sponsored by Advice Pharma Group srl studied tre…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma [Phase 1]
A Phase 1 study evaluating the safety and potential activity of venetoclax in combination with ixazomib citrate and dexamethasone in relapse…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]
A Phase 1 study of ION251 in patients with relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
Pfizer conducted a study to evaluate the effectiveness of Elranatamab in relapsed or refractory multiple myeloma; the trial has completed an…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Cryocompression Therapy for Peripheral Neuropathy in Patients With Multiple Myeloma [NA]
A clinical trial evaluating cryocompression therapy for chemotherapy-induced peripheral neuropathy in patients with multiple myeloma was ter…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 study of novel regimens for relapsed or refractory multiple myeloma has been terminated.